References:

1.     Ferreira M, Davies SL, Butler M, Scott D, Clark M, Kumar P. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1993; 33:1633-7

2.     Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Medicine 1997; 3:725-6

3.     Janatuinen EK, Pikkarainen PH, Kempainen TA, Kosma VM, Jarvinen RM, Uusitupa MI, Julkunen RJ. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1996; 334:865-6

4.     Simon D, Brandt LJ. Diarrhea in patients with the acquired immunodefficiency syndrome. Gastroenterology 1993; 106:1238-42

5.     Ehrenpreis ED,  Carlson SJ,  Boorstein HL,  Craig RM. Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 1994; 39:2159-62

6.     Ullrich R,  Schneider T,  Heise W,  Schmidt W,  Averdunk R,  Riecken EO, Zeitz M. Serum carotene deficiency in HIV-infected patients. Berlin Diarrhoea/Wasting Syndrome Study Group, AIDS 1994;  8:661-5

7.     Steuerwald M,  Bucher HC,  Muller-Brand J,  Gotze M,  Roser HW,  Gyr K. HIV-enteropathy and bile acid malabsorption: response to cholestyramine. Am J Gastroenterol 1995;  90:2051-3

8.     Koch J,  Garcia-Shelton YL,  Neal EA,  Chan MF,  Weaver KE,  Cello JP. Steatorrhea: a common manifestation in patients with HIV/AIDS. Nutrition 1996;  12:507-10

9.     Lambl BB,  Federman M,  Pleskow D, Wanke CA. Malabsorption and wasting in AIDS patients with   microsporidia and pathogen-negative diarrhea. AIDS 1996; 10:739-44

10.  Ott M, Lembcke B, Fischer H, Jäger R, Polat H, Geier H et al. Early changes of body weight in human immunodefficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am J Clin Nutr 1993; 57:15-9

11.  Relman AD, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus in Whipple“s disease. N Engl J Med 1992; 327:293-301

12.  Rao SS,  Dundas S,  Holdsworth CD. Intestinal lymphangiectasia secondary to radiotherapy and chemotherapy. Dig Dis Sci 1987;  32:939

13.  Malek NP, Ocran K, Tietge UJ et al. A case of the yellow nail syndrome associated with massive chylous ascites, pleural and pericardial effusions. Z Gastroenterol 1996; 34: 763

14.  Aoyagi K, Iida M, Yao T et al. Characteristic endoscopic features of intestinal lymphangiectasia: correlations with histological findings. Hepatogastroenterology 1997; 44:133

15.  Jeffries GH, Chapman A, Sleisenger MH. Low-fat diet in intestinal lymphangiectasia: its effect on albumin metabolism. N Engl J Med 1964; 270:761

16.  Lester LA,  Rothberg RM,  Krantman HJ,  Shermeta DW. Intestinal lymphangiectasia and bilateral pleural effusions: effect of dietary therapy and surgical intervention on immunologic and pulmonary  parameters. J Allergy Clin Immunol 1986;  78:891

17.  Tift WL, Lloyd JK. Intestinal lymphangiectasia: long-term results with MCT diet. Arch Dis Child 1975; 50:269

18.  Bac DJ,  Van Hagen PM,  Postema PT,  ten Bokum AM,  Zondervan PE,  van Blankenstein M. Octreotide for protein-losing enteropathy with intestinal lymphangiectasia. Lancet 1995;  345:1639.

19.  Farthing MJ. The molecular pathogenesis of giardiasis. J Pediatr Gastroenterol Nutr  1997;  24:79-88

20.  Carroccio A,  Montalto G,  Iacono G,  Ippolito S,  Soresi M,  Notarbartolo A. Secondary impairment of pancreatic function as a cause of severe malabsorption in intestinal giardiasis: a case report. Am J Trop Med Hyg 1997;  56:599-602

21.  Milutinovic-Djuric S,  Milovic V, Popovic OS. Diagnosis of giardiasis: possible role of ileal biopsy smear. Endoscopy 1993;  25:489

22.  Popovic OS.  Milovic V. Propranolol and metronidazole for the treatment of metronidazole-resistant giardiasis. J Clin Gastroenterol 1990;  12:604-5

23.  Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med 1985; 102:197-9

24.  Caspary WF. Biguanides and intestinal absorption. Acta Hepato-Gastroenterol 1977; 24:473-80

25.  Caspary WF, Zavada I, Reimold WV, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin B12 absorption in diabetics on biguanides. Diabetologia 1977; 13:187-94

26.  Bellou A,  Aimone-Gastin I,  De Korwin JD,  Bronowicki JP,  Moneret-Vautrin A,  Nicolas JP,  Bigard MA,  Gueant JL. Cobalamin deficiency with megaloblastic anemia in one patient under long-term omeprazole therapy. J Intern Med 1996;  240:161-4

27.  Arora S, Kassarjian Z, Kraskinski SD, Croffey B, Kaplan MM, Russell RM. Effect of age on tests of intestinal and hepatic functions in healthy humans. Gastroenterology 1989; 96:1560-4

28.  Lovat LB. Age related changes in gut physiology and nutritional status. Gut 1996;  38:306-9

29.  King D,  Smith ML,  Chapman TJ,  Stockdale HR,  Lye M. Fat malabsorption in elderly patients with cardiac cachexia. Age & Ageing 1996;  25:144-9

30.  Armbrecht HJ, Zenser TV, Bruns MEH. Effect of age on intestinal calcium absorption and adaptation to dietary calcium. Am J Physiol 1979; 236: E769-73

31.  Dowling RH, Hosomi M, Stace NH, Lirussi F, Miazzi B, Levan H, Murphy GM. Hormones and polyamines in intestinal and pancreatic adaptation. Scand J Gastroenterol 1985; 20:84-95.

32.  Luk GD, Yang P. Polyamines in intestinal and pancreatic adaptation. Gut 1987; 28:95-101.

33.  Dowling RH. Update on intestinal adaptation. Triangle 1989; 27:149-164.

34.  Popovic OS, Jojic N, Necic D, Milutinovic-Djuric S, Djordjevic D. Cholylsarcosine use for bile acid replacement in massive ileal resection: the effects on steatorrhea and diarrhea, and the role of drug formulation. Arch Gastroenterohepatol (Belgrade) 1998; 17:2-8

35.  Heimburger DC, Weinsier RL. Gastrointestinal and liver diseases, in: Heimburger DC, Weinsier RL (Eds). Handbook of Clinical Nutrition, 3rd Edition, Mosby Inc., St Louis, 1997; p.424-39

36.  Alpers DH, Stenson WF, Bier DM. Nutritional planning for patients with protein and calorie deficiency, in: Alpers DH, Stenson WF, Bier DM (Eds).Manual of nutritional therapeutics, 3rd Edition, Little, Brown &Co, Boston 1995; p265-80

37.  Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease.  Am J Clin Nutr 1997;  65:564-7

38.  Wanke CA,  Pleskow D,  Degirolami PC,  Lambl BB,  Merkel K,  Akrabawi S. A medium chain triglyceride-based diet in patients with HIV and chronic diarrhea reduces diarrhea and malabsorption: a prospective, controlled trial. Nutrition 1996;  12:766-71

39.  Bruno MJ,  Haverkort EB,  Tytgat GN,  van Leeuwen DJ. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol 1995;  90:1383-93

 


Table 1. Medications used in malabsorption and    maldigestion modified from ref. [35])

____________________________________________________________________

Medication/dosage                                          Comment

____________________________________________________________________

 

Antidiarrheal agents

Loperamide (2-4 mg prn)

 

Bile acid binding resins

Cholestyramine (4 g tid)

Cholestipol (5-10 g tid)

 

Antibiotics

Metronidazole (250 mg tid)

Tetracycline (250 mg qid)

Doxycyclin (100-200 mg bid)

 

Pancreatic enzymes                                      General: 30,000 U lipase with meals

KreonR                                                                       Acid-resistant   micropellets

ViocaseR (1 g with meals)                                Effect improved if given with

                                                                       acid-suppressing drugs

 

Vitamins & Minerals

Vitamin A (100,000-200,000 U bid)               Maintenance: 25,000-50,000 U/day

Vitamin D (30,000-50,000 U/day)                  Monitor serum calcium

Vitamin K (4-12 mg/day)

Folic acid (5 mg/day)                                      Maintenance: 1 mg/day

Vitamin B12 (1 mg sc;

            then 100 µg q 1-2 mo)

Calcium gluconate (5-10 mg tid)                      Monitor serum calcium

Calcium carbonate (500 mg bid)                      Monitor serum calcium

Magnesium gluconate (1-4 g qid)                    

Ferrous sulfate (325 mg tid)

____________________________________________________________________

 

(All dosages are per os, if not otherwise stated)

 

 

 

Hosted by www.Geocities.ws

1 1